Skip to main content
Clinical Trials/NCT00799084
NCT00799084
Completed
Phase 2

Automated Telephone Monitoring for Symptom Management

Michigan State University1 site in 1 country526 target enrollmentApril 2003
ConditionsCarcinoma

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Carcinoma
Sponsor
Michigan State University
Enrollment
526
Locations
1
Primary Endpoint
Lower reported mean severity index among 7 prevalent symptoms
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

To improve the management of symptoms, patients with cancer undergoing chemotherapy will be monitored using an automated telephone system to record the severity of 15 prevalent symptoms for up to 8 consecutive weeks. Outcomes include; significant reduction in symptom severity and improvement in health states.

Detailed Description

Overview: Prevalent symptoms among patients undergoing chemotherapy include: pain, fatigue, dry mouth, constipation, anorexia, nausea, sleep disturbance, shortness of breath or difficulty breathing, as well as psychological symptoms such as depression and anxiety. A survey of 1000 patients with cancer indicated that close to a quarter reported 10-12 symptoms. Given the impact of symptoms upon physical function, work, emotional distress, and hospitalizations, it is critical that strategies be developed and tested to improve symptom management. This trial of a behavioural intervention for symptom management is significant because: 1) it contrasts a proactive approach, individualized to patients' symptom management needs, with a more conventional model that places responsibility on the patient for symptom management; 2) it controls for the method of delivery and the use of printed material; 3) it targets prevalent symptoms known to affect cancer patients undergoing chemotherapy; 4) it examines the relative effects of each arm, in terms of symptom severity (primary outcome), impact on patients' physical and social roles, and emotional distress; and 5) it explores these outcomes in terms of their impact on the use of services and costs of care. Goal: The goal of this randomized trial is to determine if a nurse delivered Patient Assisted Management of Symptoms (PAMS) intervention individualized to patients' needs for symptom management, delivered by telephone, when compared to Telephone Information and Monitoring of Symptoms (TIMS) where symptoms are only monitored by telephone, with references to the symptom management toolkit will reduce symptom severity, improve physical function, and other outcomes.

Registry
clinicaltrials.gov
Start Date
April 2003
End Date
November 2006
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Bill Given

Professor

Michigan State University

Eligibility Criteria

Inclusion Criteria

  • 21 years of age or older
  • solid tumor cancer diagnosis
  • receiving chemotherapy treatment

Exclusion Criteria

  • Emotional or psychology disorder for which patient is receiving treatment
  • does not speak English
  • does not have access to a telephone
  • difficulty hearing on the telephone

Outcomes

Primary Outcomes

Lower reported mean severity index among 7 prevalent symptoms

Time Frame: 9 weeks, 15 weeks

Secondary Outcomes

  • Reduced impact of physical role performance, improved social functioning, and reduced emotional distress; improved levels of communication between patients and providers; and improved patient satisfaction with care.(9 weeks, 15 weeks)

Study Sites (1)

Loading locations...

Similar Trials